Barclays PLC Ars Pharmaceuticals, Inc. Comm Transaction History

Barclays PLC

$854 Billion
Q3 2025

A detailed history of Barclays PLC transactions in Ars Pharmaceuticals, Inc. Comm stock. As of the latest transaction made, Barclays PLC holds 228,569 shares of SPRY stock, worth $0. This represents 0.0% of its overall portfolio holdings.

Number of Shares

228,569

Previous 622,235 63.27%

Holding current value

Previous $10.9 Million 100.0%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 12, 2025	SELL	N/A	-393,666 Reduced 63.27%	228,569 $0
Q2 2025 Aug 13, 2025	BUY	N/A	490,200 Added 371.27%	622,235 $10.9 Million
Q1 2025 May 15, 2025	SELL	N/A	-26,145 Reduced 16.53%	132,035 $1.66 Million
Q4 2024 Feb 13, 2025	BUY	N/A	46,514 Added 41.65%	158,180 $1.67 Million
Q3 2024 Nov 15, 2024	BUY	N/A	73,127 Added 189.75%	111,666 $1.62 Million

Q2 2024 Aug 14, 2024	BUY	N/A	8,666 Added 29.01%	38,539 $328,000
Q1 2024 May 15, 2024	SELL	N/A	-10,501 Reduced 26.01%	29,873 $306,000
Q4 2023 Feb 15, 2024	BUY	N/A	22,597 Added 127.11%	40,374 $222,000
Q3 2023 Nov 07, 2023	SELL	N/A	-2,683 Reduced 13.11%	17,777 $66,000
Q2 2023 Aug 03, 2023	SELL	N/A	-15,322 Reduced 42.82%	20,460 $138,000
Q1 2023 May 04, 2023	BUY	N/A	14,972 Added 71.95%	35,782 $232,000
Q4 2022 Feb 13, 2023	BUY	N/A	825 Added 4.13%	20,810 $177,000
Q3 2022 Nov 03, 2022	SELL	N/A	-912 Reduced 4.36%	19,985 $106,000
Q2 2022 Aug 12, 2022	BUY	N/A	3,792 Added 22.17%	20,897 $89,000
Q1 2022 May 16, 2022	BUY	N/A	17,105 New	17,105 $60,000

About ARS PHARMACEUTICALS, INC. COMM

Ticker SPRY

More about SPRY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.

Account